{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T14:02:25Z","timestamp":1761919345786,"version":"build-2065373602"},"reference-count":18,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2011,6,1]],"date-time":"2011-06-01T00:00:00Z","timestamp":1306886400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2011,6,1]],"date-time":"2011-06-01T00:00:00Z","timestamp":1306886400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["La Revue de M\u00e9decine Interne"],"published-print":{"date-parts":[[2011,6]]},"DOI":"10.1016\/j.revmed.2010.06.010","type":"journal-article","created":{"date-parts":[[2010,7,15]],"date-time":"2010-07-15T05:06:37Z","timestamp":1279170397000},"page":"e72-e75","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Enc\u00e9phalopathie hyperammoni\u00e9mique au valproate de sodium"],"prefix":"10.1016","volume":"32","author":[{"given":"B.","family":"Granel","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Gavaret","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"X.","family":"Le Baut","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N.","family":"Sautereau","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Rodriguez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Rossi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Bagn\u00e8res","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.-L.","family":"Demoux","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Y.","family":"Franc\u00e8s","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.revmed.2010.06.010_bib1","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1111\/j.1528-1157.1982.tb06195.x","article-title":"Stuporous episodes during treatment with sodium valproate: report of seven cases","volume":"23","author":"Marescaux","year":"1982","journal-title":"Epilepsia"},{"key":"10.1016\/j.revmed.2010.06.010_bib2","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/0022-510X(83)90217-4","article-title":"Le valproate de sodium\u00a0: une drogue hyperammoni\u00e9miante. \u00c9tude chez l\u2019\u00e9pileptique et chez le volontaire sain","volume":"58","author":"Marescaux","year":"1983","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.revmed.2010.06.010_bib3","first-page":"100","article-title":"Hyperammonaemia and hepatotoxicity during chronic valproate therapy: enhancement by combination with other antiepileptic drugs","volume":"22","author":"Ratnaike","year":"1986","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.revmed.2010.06.010_bib4","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1177\/106002809302700510","article-title":"Valproate-induced coma: case report and literature review","volume":"27","author":"Duarte","year":"1993","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.revmed.2010.06.010_bib5","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1111\/j.1528-1157.1994.tb02928.x","article-title":"Effects of valproate and citrulline on ammonium-induced encephalopathy","volume":"35","author":"Stephens","year":"1994","journal-title":"Epilepsia"},{"key":"10.1016\/j.revmed.2010.06.010_bib6","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1212\/WNL.51.1.292","article-title":"Fulminant progression of demyelinating disease after valproate-induced encephalopathy","volume":"51","author":"Blindauer","year":"1998","journal-title":"Neurology"},{"key":"10.1016\/j.revmed.2010.06.010_bib7","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1111\/j.1528-1157.2000.tb00263.x","article-title":"Valproic acid-induced hyperammonemic encephalopathy with triphasic waves","volume":"41","author":"Kifune","year":"2000","journal-title":"Epilepsia"},{"key":"10.1016\/j.revmed.2010.06.010_bib8","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1023\/A:1021918104127","article-title":"Valproate-induced hyperammonemic encephalopathy","volume":"17","author":"Verrotti","year":"2002","journal-title":"Metab Brain Dis"},{"key":"10.1016\/j.revmed.2010.06.010_bib9","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1046\/j.1528-1157.2002.42201.x","article-title":"Valproate-induced encephalopathy: assessment with MR imaging and 1H MR spectroscopy","volume":"43","author":"Ziyeh","year":"2002","journal-title":"Epilepsia"},{"key":"10.1016\/j.revmed.2010.06.010_bib10","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1007\/s00535-004-1502-y","article-title":"Hyperammonemia-induced encephalopathy due to ornithine transcarbamylase deficiency in an adult woman: identification of novel missense mutations","volume":"40","author":"Tanaka","year":"2005","journal-title":"J Gastroenterol"},{"key":"10.1016\/j.revmed.2010.06.010_bib11","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/S0013-7006(05)82378-4","article-title":"Troubles cognitifs, syndrome extrapyramidal et hyperammoni\u00e9mie sous traitement thymor\u00e9gulateur par divalproate de sodium\u00a0: \u00e0 propos d\u2019un cas","volume":"31","author":"Ricard","year":"2005","journal-title":"Encephale"},{"key":"10.1016\/j.revmed.2010.06.010_bib12","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1093\/ageing\/afm019","article-title":"Is valproate encephalopathy under-recognised in older people? A case series","volume":"36","author":"Beyenburg","year":"2007","journal-title":"Age Ageing"},{"key":"10.1016\/j.revmed.2010.06.010_bib13","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1503\/cmaj.061272","article-title":"A case of valproate-induced hyperammonemic encephalopathy: look beyond the liver","volume":"177","author":"Alqahtani","year":"2007","journal-title":"CMAJ"},{"key":"10.1016\/j.revmed.2010.06.010_bib14","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1176\/jnp.2008.20.3.369","article-title":"Valproate-induced hyperammonemic encephalopathy without cognitive sequelae: a case report in the psychiatric setting","volume":"20","author":"Dealberto","year":"2008","journal-title":"J Neuropsychiatry Clin Neurosci"},{"key":"10.1016\/j.revmed.2010.06.010_bib15","doi-asserted-by":"crossref","first-page":"549","DOI":"10.5694\/j.1326-5377.2008.tb01780.x","article-title":"Hepatic encephalopathy precipitated by sodium valproate therapy","volume":"188","author":"Subhash","year":"2008","journal-title":"Med J Aust"},{"key":"10.1016\/j.revmed.2010.06.010_bib16","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1600-0404.2006.00655.x","article-title":"Valproate-induced hyperammonemic encephalopathy","volume":"114","author":"Segura-Bruna","year":"2006","journal-title":"Acta Neurol Scand"},{"key":"10.1016\/j.revmed.2010.06.010_bib17","series-title":"Electroencephalography. Basic principles, clinical applications, and related fields, Niedermeyer","first-page":"701","article-title":"EEG, drugs effects and central nervous system poisoning. Chapter 34","author":"Bauer","year":"2005"},{"key":"10.1016\/j.revmed.2010.06.010_bib18","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/S0278-5846(03)00166-0","article-title":"Asterixis and toxic encephalopathy induced by gabapentin","volume":"28","author":"Sechi","year":"2004","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"}],"container-title":["La Revue de M\u00e9decine Interne"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S024886631000826X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S024886631000826X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T16:28:13Z","timestamp":1759336093000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S024886631000826X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,6]]},"references-count":18,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2011,6]]}},"alternative-id":["S024886631000826X"],"URL":"https:\/\/doi.org\/10.1016\/j.revmed.2010.06.010","relation":{},"ISSN":["0248-8663"],"issn-type":[{"type":"print","value":"0248-8663"}],"subject":[],"published":{"date-parts":[[2011,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Enc\u00e9phalopathie hyperammoni\u00e9mique au valproate de sodium","name":"articletitle","label":"Article Title"},{"value":"La Revue de M\u00e9decine Interne","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.revmed.2010.06.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2010 Soci\u00e9t\u00e9 nationale fran\u00e7aise de m\u00e9decine interne (SNFMI). Published by Elsevier Masson SAS All rights reserved.","name":"copyright","label":"Copyright"}]}}